Objective To explore the expression of CD59 antigen from patients with haematologicalmalignancies and its clinical significance.
目的探讨CD5 9抗原在血液系统恶性肿瘤患者红细胞及成熟粒细胞上的表达及意义。
2
Patients with haematologicalmalignancies receiving intensive chemotherapy and requiring hospitalization were randomized in a double-blind, placebo-controlled single-centre trial.